As shown in Figure 6B, the prophylactic mD8-FAT1-OMVs immunization followed by the therapeutic immunization with peptides-absorbed OMVs resulted in a 70% tumor inhibition, the average tumor size at day 25 being 312 ± 76.4 mm3. This evidence concerns the gene FAT1 and neoplasm.